Trials / Completed
CompletedNCT01520896
Study in Healthy Volunteers to Investigate the Effects of Ketoconazole on the Pharmacokinetics of NKTR-118
An Open-label, 1-sequence, 3-period, 3-treatment, Crossover Study to Assess the Effects of Ketoconazole on the Pharmacokinetics of NKTR-118 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Study in healthy volunteers to investigate the effects of Ketoconazole on the Pharmacokinetics of NKTR-118
Detailed description
An Open-label, 1-sequence, 3-period, 3-treatment, Crossover Study to Assess the Effects of Ketoconazole on the Pharmacokinetics of NKTR-118 in Healthy Subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NKTR-118 | Oral 25 mg |
| DRUG | Ketoconazole | Oral 400 mg |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2012-01-30
- Last updated
- 2014-10-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01520896. Inclusion in this directory is not an endorsement.